UCSF Benioff Children's Hospital Antimicrobial Susceptibility: Pseudomonas aeruginosa

PrintPrintPDFPDF

The table below details the percent susceptibility of inpatient isolates of Pseudomonas aeruginosa to single agents and to the combination of antimicrobials indicated (number to the right of the arrow).  Excludes isolates from patients with cystic fibrosis.  Data are from 2015-2017.

 MER=meropenem; TOB=tobramycin; PIPTAZ=piperacillin/tazobactam; CFPM=cefepime; CIP=ciprofloxacin

 Population

Number of Isolates

PIPTAZ -->

PIPTAZ + CIP

PIPTAZ -->

PIPTAZ + TOB

CFPM -->

CFPM + CIP

CFPM -->

CFPM + TOB

MER  -->

MER + CIP

MER -->

MER + TOB

All inpatient/ED isolates

118

85%--> 100%

85% --> 98%

91% --> 100%

91% --> 97%

87% --> 100%

87% --> 98%

ICU*

49

80% --> 100%

80% --> 96%

88% --> 100%

88% --> 94%

86% --> 100%

86% --> 96%

non-ICU

69

88% --> 100%

88% --> 100%

93% --> 100%

93% --> 98%

88% --> 100%

88% --> 100%

* ICU = combined ICN, PICU and CICU - 9 isolates from ICN, remainder from PICU, PCICU